ABOUT THIS EPISODE
Host: Jennifer Caudle, DO
Guest: Stefanie Cribb, PharmD
Guest: Ryan Haumschild, PharmD
Guest: Jennifer Rubin
Guest: Ira Steinberg, MD
Guest: Stefanie Cribb, PharmD
Guest: Ryan Haumschild, PharmD
Guest: Jennifer Rubin
Guest: Ira Steinberg, MD
There’s been a lot of focus recently on biosimilars and their potential role in evolving the healthcare system. We're digging in deeper to understand what makes biosimilars so exciting. Joining Dr. Jennifer Caudle to discuss the biosimilar approval process and the important commitment supporting healthcare providers and patients in their adoption is a panel of experts: Dr. Stefanie Cribb, Dr. Ira Steinberg, and Ms. Jennifer Rubin from Coherus Biosciences and Dr. Ryan Haumschild from the Emory Healthcare and Winship Cancer Institute.
© 2022 Coherus BioSciences
C1122-COH-P829
English
United States
IN THIS EPISODE
TRANSCRIPT 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
SEARCH PAST EPISODES
Search past episodes of Medical Industry Feature.
OTHER EPISODES IN THIS PODCAST
Host: Jennifer Caudle, DO, FACOFP
Guest: Laura Sass, MD
Pediatric influenza carries a significant clinical burden, with children under four experiencing one of the highest rates of influenza-related illness, healthcare visits, and hospitalization.1,2 Seasonal influenza vaccination re…
What do large registry data reveal about outcomes after intraocular foreign body removal, and how should those findings shape surgical planning and patient counseling? In this episode of New Retina Radio Journal Club with VBS, Jordan Deaner, MD, moderates a discussion with Vaidehi Dedania, MD, and …
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Erin D. Michos, MD, MHS
Severe hypertriglyceridemia (sHTG) affects more than 3 million people, but it often flies under the clinical radar.1-3 When triglycerides are at or above a 500 mg/dL threshold, it’s no longer just an isolated lab…
Host: Maria Berrocal
How much money are retina surgeons losing on secondary IOL procedures? In this episode of Clinical Minute: Retina, host Maria Berrocal, MD, speaks with Nimesh "Nemo" Patel, MD, whose research uncovered how many cases are unprofitable under current Medicare reimbursem…
Guest: Howard Fine, M.D.
Dr. Howard Fine, a neuro-oncologist at NewYork-Presbyterian and Weill Cornell Medicine, discusses how a new approach to glioblastoma research may expand treatment options and advance precision oncology. His preclinical model, GLICO, uses cerebral organoids, or mi…
Disclaimer: The podcast and artwork embedded on this page are from ReachMD, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.
EDIT
Thank you for helping to keep the podcast database up to date.
